Ketamine and Psychedelic Therapy in Burlington, VT

How to Find Ketamine Care and a Psychedelic Therapist in Burlington

The fastest way to find ketamine therapy near you in Burlington is to choose between two paths: a guided at-home telehealth program, or an in-clinic provider you visit in person. Most people searching for a psychedelic therapist in Burlington are really asking where they can legally start now, and the honest answer is ketamine, because it is the only psychedelic-class treatment that is legal and prescribable in Vermont today.

With Mindbloom, the process starts with an online clinical evaluation. If ketamine therapy is a good fit for you, a licensed clinician prescribes a structured program you complete from home, with remote monitoring and a required peer treatment monitor present during sessions. That means a Burlington resident can begin without driving to a clinic or joining a waitlist. If you prefer an in-person setting, Burlington has a small number of ketamine providers and Spravato prescribers, covered in the options below.

Whichever path you choose, ketamine care is a prescription medical treatment, not a retail product. A licensed clinician confirms eligibility before treatment begins, which is a safeguard rather than a hurdle.

Ketamine and Psychedelic Therapy Near You Across the Burlington Area

Because Mindbloom is delivered by telehealth, ketamine therapy is available anywhere in the Burlington metro, not just downtown. That covers Burlington proper and the surrounding Chittenden County communities, so "ketamine therapy near me" resolves to your home rather than a specific address.

The at-home program reaches South Burlington, Winooski, Essex and Essex Junction, Williston, Colchester, and Shelburne, along with the rest of the greater Burlington area. In-clinic options are concentrated in Burlington and a few inner suburbs, so for many outlying towns the at-home path is the most practical way to access care close to home.

Your Ketamine and Psychedelic Therapy Options in Burlington

There are a few real ways to get ketamine or psychedelic-class therapy in the Burlington area. They differ in where treatment happens, the format, and cost. This comparison is by modality, since what matters is the type of care, not one clinic versus another.

Many people arrive here searching for psychedelic therapy, thinking of psilocybin, MDMA, LSD, or ayahuasca. None of those are legally available for therapy in Vermont: psilocybin and MDMA remain restricted, MDMA-assisted therapy is not FDA-approved or available, and the others are neither legal nor a Mindbloom service. That is exactly why ketamine is the psychedelic-class therapy you can legally start now in Burlington, and with Mindbloom you do it from home. Even against psilocybin, Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ¹⁰

The at-home difference is the Mindbloom differentiator: rather than repeated clinic visits, you get clinician-guided at-home ketamine therapy in Vermont on a personalized schedule, at a lower per-session cost. You can also see how at-home ketamine compares with in-clinic IV, and full pricing for program details.

What Ketamine Therapy Can Help With

Depression is the flagship reason people begin ketamine therapy, and it is Mindbloom's primary indication. Ketamine treatment for depression is available across Burlington via telehealth, and depression is where the evidence base is strongest.

Beyond depression, Mindbloom's programs also address anxiety, PTSD, grief, burnout, and sleep, each with tailored preparation and integration rather than a one-size prescription. PTSD is worth calling out for Vermont's veterans and first responders: Mindbloom is the only at-home ketamine therapy provider with peer-reviewed PTSD outcomes. Mindbloom does not treat conditions its evidence does not support, so you will not see claims here for chronic pain, OCD, or addiction.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions and is one of the largest at-home psychedelic-therapy providers. The outcomes below draw on Mindbloom's peer-reviewed subcutaneous study, which covers depression, anxiety, and PTSD in one study¹, alongside two earlier peer-reviewed studies of its sublingual protocol⁵ ⁶ and research preprints extending the evidence to grief, burnout, and sleep. Together that is the largest published evidence base in at-home ketamine therapy. Individual results vary.

¹ Subcutaneous, six-session course (Parks AC et al. J Med Internet Res. 2026). Response = at least 50% reduction (PHQ-9/GAD-7) or 10 points (PCL-5); remission = final PHQ-9/GAD-7 below 5, or at least a 10-point reduction and PCL-5 below 33. ² Swain et al. 2026 (grief, PGD-13), n=503. ³ Swain et al. (burnout, MBI-GS), n=395. ⁴ Swain et al. 2026 (sleep, PHQ-9 Item 3), n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on at least one dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0).

Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How those outcomes compare with other treatments, each a study-to-study comparison:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs ~41%), and reached faster.¹ ⁷
• Mindbloom's reported anxiety response is comparable to the rate reported in a study of first-line SSRIs, without a daily pill.¹ ⁸
• Mindbloom's reported PTSD response rate is about 32% higher than the rate reported in a study of first-line SSRIs (76.7% vs 58%).¹ ⁹

Is Ketamine or Psychedelic Therapy Legal in Vermont?

Yes for ketamine. Ketamine is legal, FDA-approved as a Schedule III medication, prescribable by a licensed clinician, and available now via telehealth in Burlington. That is what makes at-home treatment with Mindbloom possible statewide.

Psilocybin and MDMA are a different story. Neither is legal for therapy in Vermont. The state has been studying the question through a legislative Psychedelic Therapy Advisory Working Group, which concluded in 2024 that Vermont is not ready to authorize psychedelic-assisted therapy and recommended more research first.¹² Bills to decriminalize or create a therapeutic psilocybin program have been introduced but none has become law, so as of now there is no licensed psilocybin or MDMA therapy available anywhere in the state. Ketamine remains the psychedelic-class therapy you can legally begin today.

How At-Home Ketamine Therapy Works

The path is straightforward. You complete an online clinical evaluation, and a licensed clinician reviews your history and decides whether ketamine therapy is appropriate. If it is a good fit, they prescribe a program and Mindbloom ships your treatment along with the supportive materials you need.

Sessions happen at home on a clinician-guided schedule, with a required peer treatment monitor present, guided preparation beforehand, and integration afterward to help the experience translate into lasting change. Many clients feel meaningful relief early in the program, with benefits building cumulatively across the full course rather than arriving all at once.

Safety, Candidacy, and Cost

Ketamine therapy has a well-characterized safety profile in Mindbloom's published data, with serious adverse events occurring in fewer than 0.1% of participants across its studies. It is not right for everyone, which is why every client starts with a clinical evaluation and a licensed clinician confirms eligibility before treatment begins.

On cost, Mindbloom's programs run $165 to $215 per session depending on program length, structured as 6, 12, or 18 sessions and paid out of pocket, with HSA and FSA funds accepted and possible out-of-network reimbursement. In-clinic IV ketamine in the Burlington area runs higher, roughly $525 to $900 or more per session.¹³ Spravato, an in-clinic option, may be covered by insurance for people who qualify, subject to the insurer's prior authorization; otherwise it is out of pocket. Mindbloom is also built to work alongside your existing care, so you can keep your current therapist while adding ketamine therapy. If you want to see whether it is a fit, eligibility begins with an online clinician evaluation.